The use of immunosuppressive and combination treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) has increased…
Articles by Margarida Maia, PhD
Milk-derived extracellular vesicles — very small, natural particles from cow’s milk — were shown to safely reduce inflammation and scarring…
In people with diffuse cutaneous systemic sclerosis (dcSSc), certain skin features, including levels of specific molecules and cells, depend…
More than a third of adults with systemic sclerosis (SSc) who develop interstitial lung disease (ILD) see their condition…
Researchers in China have identified five genes — COL1A2, COL3A1, COL15A1, THY-1, and CCL19 — that may play a key…
Galderma is launching a Phase 2 clinical trial to test nemolizumab, an antibody the company is developing to ease…
Levels of certain types of immune cells are abnormally high in some people with systemic sclerosis (SSc), and this…
Adicet Bio expects adults with systemic sclerosis (SSc) soon to start enrolling in its ongoing Phase 1…
The presence of different autoantibodies specific to systemic sclerosis (SSc) can determine how the disease is likely to progress…
Immunosuppressive medications may help to reduce inflammation in the heart and the overall burden of primary heart involvement that is…